(Q39431221)

11 September 2017

title

Role for Class I histone deacetylases in multidrug resistance (English)

1 reference

11 September 2017

main subject

multiple drug resistance

1 reference

Yichun Xu

1

1 reference

11 September 2017

Zijing Jiang

2

1 reference

11 September 2017

Peihao Yin

3

1 reference

11 September 2017

Qi Li

4

1 reference

11 September 2017

Jianwen Liu

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

28 November 2011

1 reference

Experimental Cell Research

11 September 2017

published in

1 reference

11 September 2017

volume

318

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

177-186

1 reference

Histone deacetylase inhibitors as new cancer drugs

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

A review of depsipeptide and other histone deacetylase inhibitors in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

HDAC family: What are the cancer relevant targets?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Role for histone deacetylase 1 in human tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Multidrug resistance in cancer: role of ATP-dependent transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

The Role of ABC Transporters in Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Strategies for reversing drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

The ABC transporter structure and mechanism: perspectives on recent research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Substrate recognition and transport by multidrug resistance protein 1 (ABCC1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Histone deacetylase inhibitor apicidin-mediated drug resistance: involvement of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Clinical, cellular, and molecular aspects of cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Antimetastatic effect of prodigiosin through inhibition of tumor invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Inhibitors of multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Multidrug resistance: molecular mechanisms and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Transcriptional regulation by the Sp family proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.11.010

10.1016/J.YEXCR.2011.11.010

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference